Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00323791
Status:
TERMINATED
Last Update Posted:
2009-12-11
First Post:
2006-05-08
Brief Title:
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
Sponsor:
Organization:
Rutgers The State University of New Jersey